| 
Results for amylin. Search took 0.11 seconds.
Victoza: New Diabetes Drug, Better Than Byetta?
in Daily Diabetic, on June 14, 2009
... thought it was the best thing that ever happened to diabetes treatment...
Byetta is a product of Amylin Pharmaceuticals and Eli Lily....
New Survey Shows A Disconnect Between Doctors And Patients On Diabetes And Weight
in Daily Diabetic, on January 22, 2009
...0 - report having these discussions with such frequency.
The Behavioral Diabetes Institute and AMYLIN PHARMACEUTICALS collaborated on the design of a national survey, which was sponsored by Amy...
FDA Warning: Byetta is Linked To Pancreatitis and Death
in Daily Diabetic, on August 18, 2008
... therapies other than Byetta in patients with a history of pancreatitis
Byetta is a product of Amylin Pharmaceuticals, Inc. and Eli Lilly and Company .
Just when we thought that a wonderful tr...
Once-weekly Exenatide Long-acting Release (LAR) Injection Found Superior Over Twice-Daily BYETTA® (exenatide) Injection
in Daily Diabetic, on November 6, 2007
...ide) injection taken twice daily in patients with type 2 diabetes have recently been announced by Amylin Pharmaceuticals, Inc. , Eli Lilly and Company and Alkermes, Inc. .
Once-weekly exenatide,...
SYMLIN® Pen-Injector Devices, Approved by the FDA
in Daily Diabetic, on October 2, 2007
...The maker of BYETTA® (exenatide) injection, Amylin Pharmaceuticals , is also the maker of SYMLIN® (pramlintide acetate) injection, approved by the FDA in March for insulin-using type 1 and type ...
Exenatide, Better than Insulin Glargine
in Daily Diabetic, on September 22, 2007
...ycemic improvement, on top of losing weight - according to the study results recently announced by Amylin Pharmaceuticals, Inc. and Eli Lilly and Company .
In this study, people with type 2 diabe...
BYETTA® Can Sustain Blood Glucose Control in Type 2 Diabetics
in Daily Diabetic, on July 2, 2007
...iabetes better control their blood sugar levels."
BYETTA® (exenatide) is a product of Amylin Pharmaceuticals, Inc. and E li Lilly and Company .
Find more details of the BYETTA® study from L...
Poison Lizard-Derived Drug BYETTA, Launched in the UK
in Daily Diabetic, on May 13, 2007
...omes in a pen that has the patient's daily doses of medicine measured.
BYETTA is a product of Amylin Pharmaceuticals and Eli Lilly and is the first in the new class of drugs called incretin ...
Byetta Makes Its Way Overseas...Finally
in Daily Diabetic, on November 16, 2006
...hich Lilly is counting on to become a key future source of revenue.
Lilly co-developed Byetta with Amylin Pharmaceuticals, a San Diego-based company.
Byetta is given to diabetic patients to help con...
Top 20 Molecular Millionaires
in The Biotech Weblog, on May 31, 2006
... Leonard Schleifer, M.D., Ph.D., Regeneron Pharmaceuticals
7. Orville G. Kolterman, Ph.D., Amylin Pharmaceuticals
8. Paul J. Maddon, M.D., Ph.D., Progenics
9. Leonard Bell, M.D., Alexion...
The Newest Treatment For Diabetes: Lizard Venom?
in Daily Diabetic, on February 12, 2006
...esearchers found the protein lasts longer than other diabetes drugs, and the pharmaceutical company Amylin is developing an exendin-based drug.
The lizard can make the protein by gnawing on anything ...
Review Articles on Drug Discovery
in The Biotech Weblog, on September 27, 2005
...on in somatic cells.
And Fresh From The Pipeline: Exenatide
In April 2005, exenatide (Byetta; Amylin/Eli Lilly) was approved by the US FDA as an adjunctive therapy to improve blood-sugar control...